People: Johnson & Johnson (JNJ.N)
Mr. Joaquin Boix Duato is the Vice Chairman - Executive Committee of the Company. Mr. Duato joined the Company in 1989 with Janssen-Farmaceutica S.A. (Spain) and in 1997 became Managing Director of Janssen-Cilag S.p.A. (Italy). In 2000, he led Ortho Biotech Europe before relocating to the United States in 2002 to serve as Vice President, and, in 2005, President of Ortho Biotech Inc. In 2008, he was named Company Group Chairman, Ortho-Clinical Diagnostics, and in 2009, Company Group Chairman, Pharmaceuticals, where he oversaw pharmaceutical product launches and the major therapeutic franchises in Canada, the United States and Latin America. In 2011, he was named Worldwide Chairman, Pharmaceuticals, responsible for the global commercial businesses of the Janssen Pharmaceutical Companies, including functional support for the research & development organizations. In April 2016, Mr. Duato became a member of the Executive Committee and was named Executive Vice President, Worldwide Chairman, Pharmaceuticals.
|Total Annual Compensation, USD||2,944,130|
|Restricted Stock Award, USD||4,275,950|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||2,063,880|
|Fiscal Year Total, USD||9,283,960|